<DOC>
	<DOC>NCT01799382</DOC>
	<brief_summary>The purpose of the study is to determine if rapid on-site evaluation of EBUS-TBNA samples can increase the percentage of patients with advanced non-squamous non-small cell lung cancer in whom both pathologic subtyping and mutational analysis are obtained.</brief_summary>
	<brief_title>Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Age &gt; 18 years Suspected hilar or mediastinal lymph node metastasis from lung cancer Pregnancy Uncontrolled coagulopathy Refusal to sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>